Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4379)
All Articles published online
|
Nov 28, 2007 (publication date) through Dec 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Prat A, Casado E, Cortés J. New approaches in angiogenic targeting for colorectal cancer. World J Gastroenterol 2007; 13(44): 5857-5866 [PMID: 17990351 DOI: 10.3748/wjg.v13.i44.5857] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i44/5857.htm |
| Number | Citing Articles |
| 1 |
Wolfgang Lieb, Radwan Safa, Emelia J. Benjamin, Vanessa Xanthakis, Xiaoyan Yin, Lisa M. Sullivan, Martin G. Larson, Holly M. Smith, Joseph A. Vita, Gary F. Mitchell, Douglas B. Sawyer, Ramachandran S. Vasan. Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function. European Heart Journal 2009; 30(9): 1121 doi: 10.1093/eurheartj/ehp007
|
| 2 |
Preety Ghanghas, Shelly Jain, Chandan Rana, S.N. Sanyal. Chemopreventive action of non-steroidal anti-inflammatory drugs on the inflammatory pathways in colon cancer. Biomedicine & Pharmacotherapy 2016; 78: 239 doi: 10.1016/j.biopha.2016.01.024
|
| 3 |
Arundhati Jana, Nancy L. Krett, Grace Guzman, Ahmer Khalid, Ozkan Ozden, Jonas J. Staudacher, Jessica Bauer, Seung Hyun Baik, Timothy Carroll, Cemal Yazici, Barbara Jung. NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway. Oncotarget 2017; 8(23): 37377 doi: 10.18632/oncotarget.16343
|
| 4 |
S. Di Franco, M. Todaro, F. Dieli, G. Stassi. Colorectal cancer defeating? Challenge accepted!. Molecular Aspects of Medicine 2014; 39: 61 doi: 10.1016/j.mam.2013.07.001
|
| 5 |
Laura Q. M. Chow, S. Gail Eckhardt. Principles of Anticancer Drug Development. 2011; : 347 doi: 10.1007/978-1-4419-7358-0_14
|
| 6 |
Lili Nimri, Hossei Barak, Lutz Graeve, Betty Schwartz. Restoration of caveolin‐1 expression suppresses growth, membrane‐type‐4 metalloproteinase expression and metastasis‐associated activities in colon cancer cells. Molecular Carcinogenesis 2013; 52(11): 859 doi: 10.1002/mc.21927
|
| 7 |
Gesiena E. van der Wal, Annette S. H. Gouw, Jan A. A. M. Kamps, Henk E. Moorlag, Marian L. C. Bulthuis, Grietje Molema, Koert P. de Jong. Angiogenesis in Synchronous and Metachronous Colorectal Liver Metastases. Annals of Surgery 2012; 255(1): 86 doi: 10.1097/SLA.0b013e318238346a
|
| 8 |
Qiaoyan Cai, Jiumao Lin, Lihui Wei, Ling Zhang, Lili Wang, Youzhi Zhan, Jianwei Zeng, Wei Xu, Aling Shen, Zhenfeng Hong, Jun Peng. Hedyotis diffusa Willd Inhibits Colorectal Cancer Growth in Vivo via Inhibition of STAT3 Signaling Pathway. International Journal of Molecular Sciences 2012; 13(5): 6117 doi: 10.3390/ijms13056117
|
| 9 |
Xin-En Huang, Xiao-Chun Yan, Lin Wang, Zhu-Qing Ji, Li Li, Meng-Yan Liu, Ting Qian, Hui-Ling Shen, Han-Gang Gu, Yong Liu, Ming Gu, Li-Chun Deng. Thalidomide Combined with Chemotherapy in Treating Patients with Advanced Colorectal Cancer. Asian Pacific Journal of Cancer Prevention 2015; 16(17): 7867 doi: 10.7314/APJCP.2015.16.17.7867
|
| 10 |
Kei Sakamoto, Shin Maeda, Yohko Hikiba, Hayato Nakagawa, Yoku Hayakawa, Wataru Shibata, Ayako Yanai, Keiji Ogura, Masao Omata. Constitutive NF-κB Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor Growth. Clinical Cancer Research 2009; 15(7): 2248 doi: 10.1158/1078-0432.CCR-08-1383
|
| 11 |
Sidhant Jain, Meenakshi Rana, Pooja Choubey, Sahil Kumar. Schistosoma japonicum Associated Colorectal Cancer and Its Management. Acta Parasitologica 2023; 68(4): 723 doi: 10.1007/s11686-023-00707-9
|
| 12 |
Jenia Jenab-Wolcott, Bruce J Giantonio. Bevacizumab: current indications and future development for management of solid tumors. Expert Opinion on Biological Therapy 2009; 9(4): 507 doi: 10.1517/14712590902817817
|
| 13 |
Stefan K. Burgdorf, Hans J. Nielsen, Jacob Rosenberg. Immunotherapy in colorectal cancer. Scandinavian Journal of Gastroenterology 2009; 44(3): 261 doi: 10.1080/00365520802400909
|
| 14 |
LEI FAN, YUHUA LI, YANG SUN, ZHENGGANG YUE, JIN MENG, XUTAO ZHANG, RONG ZHANG, DIAN ZHANG, FENG ZHANG, QIBING MEI. Paris saponin VII inhibits metastasis by modulating matrix metalloproteinases in colorectal cancer cells. Molecular Medicine Reports 2015; 11(1): 705 doi: 10.3892/mmr.2014.2728
|
| 15 |
Arundhati Jana, Archita Das, Nancy L. Krett, Grace Guzman, Alexandra Thomas, Georgina Mancinelli, Jessica Bauer, Masuko Ushio-Fukai, Tohru Fukai, Barbara Jung, Salvatore V. Pizzo. Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancer. PLOS ONE 2020; 15(1): e0227916 doi: 10.1371/journal.pone.0227916
|
| 16 |
E.S.M. Chu, S.C.W. Sze, H.P. Cheung, K.L. Wong, Q. Liu, T.B. Ng, Y. Tong. Differential effects of anti-metastatic mechanism of Tian-Xian liquid (TXL) and its bioactive fractions on human colorectal cancer models. Journal of Ethnopharmacology 2011; 137(1): 403 doi: 10.1016/j.jep.2011.05.035
|
| 17 |
Shiwei Guo, Xuehai Pang, Lingling Peng, Miao Zhan, Lei Fan, Yu Gong, Fanyuan Kang, Yuanwei Chen. Design, synthesis and biological evaluation of deuterated Tivozanib for improving pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters 2015; 25(11): 2425 doi: 10.1016/j.bmcl.2015.03.088
|
| 18 |
Parvaneh Rafiee, Daniel J. Stein, Victoria M. Nelson, Mary F. Otterson, Reza Shaker, David G. Binion. Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). American Journal of Physiology-Gastrointestinal and Liver Physiology 2010; 298(2): G167 doi: 10.1152/ajpgi.00385.2009
|
| 19 |
Anja C. Bürgers, Eckhard Lammert. Extraerythrocytic hemoglobin – A possible oxygen transporter in human malignant tumors. Medical Hypotheses 2011; 77(4): 580 doi: 10.1016/j.mehy.2011.06.035
|
| 20 |
Sungweon Choi, Daisuke Sano, Melvina Cheung, Mei Zhao, Samar A. Jasser, Anderson J. Ryan, Li Mao, Wan-Tao Chen, Adel K. El-Naggar, Jeffrey N. Myers. Vandetanib Inhibits Growth of Adenoid Cystic Carcinoma in an Orthotopic Nude Mouse Model. Clinical Cancer Research 2008; 14(16): 5081 doi: 10.1158/1078-0432.CCR-08-0245
|
| 21 |
Subash C. Gupta, Sahdeo Prasad, Dhanya R. Sethumadhavan, Mangalam S. Nair, Yin-Yuan Mo, Bharat B. Aggarwal. Nimbolide, a Limonoid Triterpene, Inhibits Growth of Human Colorectal Cancer Xenografts by Suppressing the Proinflammatory Microenvironment. Clinical Cancer Research 2013; 19(16): 4465 doi: 10.1158/1078-0432.CCR-13-0080
|
| 22 |
Marc Chamberlain. Evolving strategies: future treatment of glioblastoma. Expert Review of Neurotherapeutics 2011; 11(4): 519 doi: 10.1586/ern.11.30
|
| 23 |
Kei Sakamoto, Shin Maeda. Targeting NF-κB for colorectal cancer. Expert Opinion on Therapeutic Targets 2010; 14(6): 593 doi: 10.1517/14728221003769903
|
| 24 |
Ling Lin, Jia Li, Ya-lan Wang, Xiao Lin. Relationship of PARG with PARP, VEGF and b-FGF in colorectal carcinoma. Chinese Journal of Cancer Research 2009; 21(2): 135 doi: 10.1007/s11670-009-0135-3
|
| 25 |
Yan Ding, Xiaobing Huang, Taiping Liu, Yong Fu, Zhangping Tan, Hong Zheng, Taoli Zhou, Jigang Dai, Wenyue Xu. The Plasmodium Circumsporozoite Protein, a Novel NF-κB Inhibitor, Suppresses the Growth of SW480. Pathology & Oncology Research 2012; 18(4): 895 doi: 10.1007/s12253-012-9519-7
|
| 26 |
Shiva Ganjali, Amirhossein Sahebkar, Elahe Mahdipour, Khadijeh Jamialahmadi, Sepideh Torabi, Saeed Akhlaghi, Gordon Ferns, Seyed Mohammad Reza Parizadeh, Majid Ghayour-Mobarhan. Investigation of the Effects of Curcumin on Serum Cytokines in Obese Individuals: A Randomized Controlled Trial. The Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/898361
|
| 27 |
Maria Di Bartolomeo, Filippo Pietrantonio, Antonia Martinetti, Roberto Buzzoni, Arpine Gevorgyan, Emilio Bajetta. Role of the Antiangiogenic Agent Bevacizumab in the Treatment of Elderly Patients with Metastatic Colorectal Cancer. Drugs & Aging 2011; 28(2): 83 doi: 10.2165/11584710-000000000-00000
|
| 28 |
Yoo Mi Lee, Yong Sik Yoon, Seon Ae Roh, Dong Hyung Cho, Jin Cheon Kim. Invasiveness of and Drug Sensitivity to Various Anti-cancer Regimens in Five Colorectal Cancer Cell Lines. Journal of the Korean Society of Coloproctology 2010; 26(2): 98 doi: 10.3393/jksc.2010.26.2.98
|
| 29 |
Erika Martinelli, Teresa Troiani, Floriana Morgillo, Michele Orditura, Fernando De Vita, Giulio Belli, Fortunato Ciardiello. Emerging VEGF-receptor inhibitors for colorectal cancer. Expert Opinion on Emerging Drugs 2013; 18(1): 25 doi: 10.1517/14728214.2013.749856
|
| 30 |
Qiaoyan Cai, Jing Lin, Ling Zhang, Jiumao Lin, Lili Wang, Daxin Chen, Jun Peng. Comparative proteomics—network analysis of proteins responsible for ursolic acid–induced cytotoxicity in colorectal cancer cells. Tumor Biology 2017; 39(3): 101042831769501 doi: 10.1177/1010428317695015
|
| 31 |
Xiao-Hong Liu, Chen-Guang Bai, Yang Yuan, De-Jun Gong, Sheng-Dong Huang. Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancer. World Journal of Gastroenterology 2008; 14(10): 1575-1581 doi: 10.3748/wjg.14.1575
|
| 32 |
Victoria L. Heath, Roy Bicknell. Anticancer strategies involving the vasculature. Nature Reviews Clinical Oncology 2009; 6(7): 395 doi: 10.1038/nrclinonc.2009.52
|
| 33 |
Flávia CM Lopes, Ana Rocha, Ana Pirraco, Luis O Regasini, Dulce HS Silva, Vanderlan S Bolzani, Isabel Azevedo, Iracilda Z Carlos, Raquel Soares. Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa
. BMC Complementary and Alternative Medicine 2009; 9(1) doi: 10.1186/1472-6882-9-15
|
| 34 |
|
| 35 |
Stéphanie Gout, Jacques Huot. Role of Cancer Microenvironment in Metastasis: Focus on Colon Cancer. Cancer Microenvironment 2008; 1(1): 69 doi: 10.1007/s12307-008-0007-2
|
| 36 |
Takanori Kanazawa, Ken Sugawara, Ko Tanaka, Shogo Horiuchi, Yuuki Takashima, Hiroaki Okada. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG–PCL nanomicelles. European Journal of Pharmaceutics and Biopharmaceutics 2012; 81(3): 470 doi: 10.1016/j.ejpb.2012.04.021
|
| 37 |
Anthony Lopez, Kazuto Harada, Maria Vasilakopoulou, Namita Shanbhag, Jaffer A. Ajani. Targeting Angiogenesis in Colorectal Carcinoma. Drugs 2019; 79(1): 63 doi: 10.1007/s40265-018-1037-9
|
| 38 |
Fengjuan Zhao, Qingyu Zhang, Chunsheng Kang, Xiaowei Cui, Tao Wang, Peng Xu, Xuan Zhou, Jian Liu, Xiaomei Song. Suppression of matrix metalloproteinase-9 expression by RNA interference inhibits SGC7901 gastric adenocarcinoma cell growth and invasion in vitro and in vivo. Medical Oncology 2010; 27(3): 774 doi: 10.1007/s12032-009-9285-x
|
| 39 |
Michael S Gordon. Antiangiogenic therapies: is VEGF-A inhibition alone enough?. Expert Review of Anticancer Therapy 2011; 11(3): 485 doi: 10.1586/era.11.5
|
| 40 |
Shahnawaz Rasheed, Peter J. McDonald, John M. Northover, Thomas Guenther. Angiogenesis and hypoxic factors in colorectal cancer. Pathology - Research and Practice 2008; 204(7): 501 doi: 10.1016/j.prp.2008.03.005
|